-
公开(公告)号:JPH1081690A
公开(公告)日:1998-03-31
申请号:JP14515597
申请日:1997-06-03
Applicant: BASF AG
Inventor: STUERMER RAINER DR , OKUDA JUN PROF DR , RITTER KURT DR
IPC: B01J31/22 , B01J31/24 , C07B53/00 , C07B61/00 , C07C7/00 , C07C209/52 , C07C211/27 , C07F5/00 , C07F5/02 , C07F5/06 , C07F7/00 , C07F7/28 , C07F9/00 , C07F9/6596 , C07F9/80 , C07F9/90 , C07F9/94 , C07F17/00
Abstract: PROBLEM TO BE SOLVED: To obtain the subject new compound capable of being used as a catalyst for enantiomeric selective hydrogenation by a simple method. SOLUTION: A chiral compound of formula I [M is an element selected from titanium, zirconium, hafnium, etc.; X is F, Cl, Br, I, H, a 1-10C alkyl, etc.; R -R are each H, a (1-10C alkyl-substituted) five to seven-membered cycloalkyl, etc.; R is Ge, Sn, O, S, etc.; R , R are each a 1-10C alkyl, a 6-15C aryl, etc.; (n) is a number obtained by subtracting 2 from the atomic valency of the M], e.g. a compound of formula II. The compound of formula I is obtained by reacting a suitably substituted cyclopentadienyl with compounds of the formulas: R Z2 and MXn (Z is F, Cl, Br, I) and subsequently reacting the reaction product with a compound of formula III (R is H, an alkali metal, etc.). Thereby, the active catalyst component used for enantiomeric selective hydrogenation can be obtained by the simple method.
-
公开(公告)号:DE4415998A1
公开(公告)日:1995-11-09
申请号:DE4415998
申请日:1994-05-06
Applicant: BASF AG
Inventor: AMBERG WILHELM DR , BERNARD HARALD DR , BUSCHMANN ERNST DR , HAUPT ANDREAS DR , JANITSCHKE LOTHAR DR , JANSSEN BERND DR , KARL ULRICH DR , KLING ANDREAS DR , MUELLER STEFAN DR , POTZOLLI BERND DE DR , RITTER KURT DR , ZIERKE THOMAS DR , THYES MARCO DR
Abstract: Compounds of formula (I) are disclosed, wherein R , R , R , and R have the meanings indicated in the description, as well as a process for the production of these compounds. The compounds are suitable for use as starting material for the synthesis of substances which have anti-tumour properties.
-
公开(公告)号:DE4415997A1
公开(公告)日:1995-11-09
申请号:DE4415997
申请日:1994-05-06
Applicant: BASF AG
Inventor: AMBERG WILHELM DR , BERNARD HARALD DR , BUSCHMANN ERNST DR , HAUPT ANDREAS DR , JANITSCHKE LOTHAR DR , JANSSEN BERND DR , KARL ULRICH DR , KLING ANDREAS DR , MUELLER STEFAN DR , POTZOLLI BERND DE DR , RITTER KURT DR , ZIERKE THOMAS DR , THYES MARCO DR
Abstract: Disclosed is the compound Me2Val-Val-MeVal-Pro-Pro-NHBzl. HCl. The compound is produced from Z-Val-Val-MeVal-Pro-OR , wherein Z and R have the meanings indicated in the description. The compound disclosed has anti-neoplastic properties.
-
公开(公告)号:CZ9801846A3
公开(公告)日:1998-09-16
申请号:CZ184698
申请日:1996-12-11
Applicant: BASF AG
Inventor: AMBERG WILHELM DR , BARLOZZARI TERESA , BERNARD HARALD DR , BUSCHMANN ERNST DR , HAUPT ANDREAS DR , HEGE HANS-GUENTHER DR , JANSSEN BERND DR , KLING ANDREAS DR , LIETZ HELMUT , RITTER KURT DR , ULRICH MARTINA DR , WEYMANN JURGEN DR , ZIERKE THOMAS DR
CPC classification number: A61K38/08
-
公开(公告)号:DE4243030A1
公开(公告)日:1994-06-23
申请号:DE4243030
申请日:1992-12-18
Applicant: BASF AG
Inventor: RITTER KURT DR , ADAM GEO DR , HELMCHEN GUENTER PROF DR , SPRINZ JUERGEN
IPC: B01J31/18 , B01J31/22 , C07C67/343 , C07F9/653 , C07F9/6539 , C07F9/6558 , C07F15/00 , C07D207/20 , C07D233/20 , C07D263/10 , C07D277/10 , C07D403/04 , C07D405/04 , C07D409/04 , C07D413/04 , C07D417/04 , C07F9/6506
Abstract: New cyclic imine derivs useful as ligands for complexing metals are of formula (I). A= O, S, CR4R5 or NR6; B= an opt inertly substd 1-3C bridging gp, opt forming part of a ring system, opt including X when X= NR4; m= 0-4; n= 0 or 1; R1 = 1-8C alkyl (opt interrupted by O or S atoms), 3-7C cycloalkyl, 1-6C aminoalkyl, 6-10C aryl (opt with inert substits), 7-10C aralkyl, p-methoxybenzyl and/or Y; Y= the residue of a natural aminoacid of formula YCH(NH2)COOH; R2 and R3= 1-8C alkyl, 3-7C cycloalkyl, 1-5C perfluoroalkyl, 1-6C alkoxy, 4-7C cycloalkoxy, 2-10C dialkylamino or 6-10C aryl, these gps opt being linked to form a ring and opt bearing inert substits; R4 and R5= H, 1-4C alkyl, 1-4C alkoxy, Ph or CH2Ph; R6= R4, COOR7 or SOOR7; R7= 1-4C alkyl, Ph, tolyl or CH2Ph; X= O or NR4; Z= N, P, As or Sb. Also claimed are transition metal complexes of formula (II). D= a non-coordinating anion; L= an organic ligand; M= a transition metal; p and q= 0-4.
-
公开(公告)号:CZ184698A3
公开(公告)日:1998-09-16
申请号:CZ184698
申请日:1996-12-11
Applicant: BASF AG
Inventor: AMBERG WILHELM DR , BARLOZZARI TERESA , BERNARD HARALD DR , BUSCHMANN ERNST DR , HAUPT ANDREAS DR , HEGE HANS-GUENTHER DR , JANSSEN BERND DR , KLING ANDREAS DR , LIETZ HELMUT , RITTER KURT DR , ULRICH MARTINA DR , WEYMANN JURGEN DR , ZIERKE THOMAS DR
Abstract: Novel peptides of the formula R R N-CHX-CO-A-B-D-E-(G)s-K in which R , R , A, B, D, E, G, K, X, and s have the meanings stated in the description, and the preparation thereof are described. The novel peptides have an antineoplastic effect.
-
公开(公告)号:CZ24398A3
公开(公告)日:1998-07-15
申请号:CZ24398
申请日:1996-07-12
Applicant: BASF AG
Inventor: AMBERG WILHELM DR , BERNARD HARALD DR , BUSCHMANN ERNST DR , HAUPT ANDREAS DR , JANSSEN BERND DR , KARL ULRICH DR , KLING ANDREAS DR , MULLER STEFAN DR , RITTER KURT DR , ZIERKE THOMAS DR
IPC: C07K1/02 , C07K1/12 , C07K5/06 , C07K5/078 , C07K5/08 , C07K5/083 , C07K5/10 , C07K5/103 , C07K7/06
Abstract: PCT No. PCT/EP96/03073 Sec. 371 Date Jan. 13, 1998 Sec. 102(e) Date Jan. 13, 1998 PCT Filed Jul. 12, 1996 PCT Pub. No. WO97/05162 PCT Pub. Date Feb. 13, 1997A process for preparing pentapeptides of the formula I where A and R1-R3 have the stated meanings, comprises assembling the pentapeptide stepwise starting from a prolinamide of the formula II where R1 and R2 have the abovementioned meanings, and eliminating the group -NR1R2 by hydrolysis where appropriate the peptide obtained in this way.
-
公开(公告)号:DE19622271A1
公开(公告)日:1997-12-04
申请号:DE19622271
申请日:1996-06-03
Applicant: BASF AG
Inventor: STUERMER RAINER DR , OKUDA JUN PROF DR , RITTER KURT DR
IPC: B01J31/22 , B01J31/24 , C07B53/00 , C07B61/00 , C07C7/00 , C07C209/52 , C07C211/27 , C07F5/00 , C07F5/02 , C07F5/06 , C07F7/00 , C07F7/28 , C07F9/00 , C07F9/6596 , C07F9/80 , C07F9/90 , C07F9/94 , C07F17/00 , C07C209/00
Abstract: Chiral compounds of formula (I) are new. M = Ti, Zr, Hf, V, Nb, Ta or a lanthanide element; X = halo, H, 1-10C alkyl, 6-15C aryl, 1-10C alkyl-(6-20C)-aryl, OR or NR R ; R , R = 1-10C alkyl, 6-15C aryl, alkylaryl, arylalkyl, fluoroalkyl or fluoroaryl with 1-10C in the alkyl group and 6-20C in the aryl group; R -R = H, 1-10C alkyl, 5-7-membered cycloalkyl optionally substituted by 1-10C alkyl, 6-15C aryl or arylalkyl, or Si(R )3; and 2 adjacent groups may form a 4-15C optionally saturated cyclic group; R = 1-10C alkyl, 3-10C cycloalkyl or 6-15C aryl; R = M )R , M )(R )-M )(R )-, M )(R )-C(R )2, C(R )(R ), OM )(R ), C(R )(R )C(R )(R ), =BR , =AlR , Ge, Sn, O, S, =SO, =SO2, =NR , =CO, =PR or =P(O)R ; R -R = H, halo, 1-10C (fluoro)alkyl, 6-10C (fluoro)aryl, 1-10C alkoxy, 2-10C alkenyl, 7-40C arylalkyl, 8-40C arylalkyl or 7-40C alkylaryl or 2 adjacent groups complete a ring; M = Si, Ge or Sn; A = B, Al, Ga, In, Tl, N, P, As, Sb or Bi; R , R = 1-10C alkyl, 6-15C aryl, 5-7-membered cycloalkyl (optionally substituted by 1-10C alkyl or groups containing heteroatoms), (CR R )mOR , (CR R )mSR or CR R ; or R +R = a 4-20C optionally saturated cyclic group, (optionally substituted by 1-10C alkyl, 6-15C aryl, heteroatoms or groups containing heteroatoms); R -R = H, 1-10C alkyl, 3-10C cycloalkyl or 6-15C aryl; R , R = 3-10C cycloalkyl, 6-15C aryl or groups containing heteroatoms; m = 1-4; n = the valency of M minus 2. Also claimed is the enantioselective hydrogenation of imines in solution, using (I) as active catalyst component.
-
公开(公告)号:CZ326096A3
公开(公告)日:1997-04-16
申请号:CZ326096
申请日:1995-04-26
Applicant: BASF AG
Inventor: AMBERG WILHELM DR , BERNARD HARALD DR , BUSCHMANN ERNST DR , HAUPT ANDREAS DR , JANITSCHKE LOTHAR DR , JANSSEN BERND DR , KARL ULRICH DR , KLING ANDREAS DR , MULLER STEFAN DR , DE POTZOLLI BERND DR , RITTER KURT DR , THYES MARCO DR , ZIERKE THOMAS DR
Abstract: PCT No. PCT/EP95/01577 Sec. 371 Date Nov. 4, 1996 Sec. 102(e) Date Nov. 4, 1996 PCT Filed Apr. 26, 1995 PCT Pub. No. WO95/30691 PCT Pub. Date Nov. 16, 1995The compound Me2Val-Val-MeVal-Pro-Pro-NHBzlxHCl is described. It is prepared from Z-Val-Val-MeVal-Pro-OR1 where Z and R1 have the meanings stated in the description. The compound shows antineoplastic activity.
-
公开(公告)号:CZ288448B6
公开(公告)日:2001-06-13
申请号:CZ326096
申请日:1995-04-26
Applicant: BASF AG
Inventor: AMBERG WILHELM DR , BERNARD HARALD DR , BUSCHMANN ERNST DR , HAUPT ANDREAS DR , JANITSCHKE LOTHAR DR , MUELLER STEFAN DR , DE POTZOLLI BERND DR , RITTER KURT DR , THYES MARCO DR , ZIERKE THOMAS DR , JANSSEN BERND DR , KARL ULRICH DR , KLING ANDREAS DR
Abstract: In the present invention, there is described pentapeptide hydrochloride of the formula Mei2Val-Val-MeVal-Pro-Pro-NHBz1.HCl, which is present in crystalline form. It is prepared from the compound of the formula Z-Val-Val-MeVal-Pro-ORe1, in which Z represents a benzyloxycarbonyl protecting group, which might be optionally substituted on the phenyl ring and Re1 represents alkyl containing 1 to 5 carbon atoms. In the present invention, there are also described intermediates for preparing the above indicated pentapeptide hydrochloride. The above-described compound exhibits antineoplastic activity.
-
-
-
-
-
-
-
-
-